Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Wearable Health Solutions, Inc. (WHSI)
Las Vegas, NV, US
Wearable Health Solutions, Inc. (WHSI) specializes in personal emergency response systems and related devices, primarily catering to individuals in the United States facing medical challenges or age-related needs. The company manufactures medical alert devices designed to summon assistance quickly during emergencies. Among its offerings is the MediPendant, an emergency alarm distinguished by its in-pendant speaker, allowing users to verbally communicate and receive responses directly through the device during an urgent situation. Another key product is iHelp, a mobile medical alert system. This device leverages T-Mobile's 2G network for remote location tracking of a user, incorporates voice prompts, and includes a dedicated dealer portal for efficient customer base management. Furthermore, the company is actively developing iHelp+3G, a cutting-edge wearable biosensor device designed for health and wellness monitoring, which will operate on a 3G network. These solutions are primarily designed to support the elderly, individuals with physical disabilities, and those residing alone. WHSI markets its offerings through its dedicated websites (medipendant.com and ihelpalarm.com) and via wholesalers. Its international reach extends to Denmark, Ireland, Bermuda, and the People's Republic of China. Originally established as Medical Alarm Concepts Holdings, Inc. in 2008, the company officially rebranded to Wearable Health Solutions, Inc. in June 2016. Its operations are headquartered in Las Vegas, Nevada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -91.67% | -99.49% | -99.93% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%-28.8% Q4'23: -35.7% (vs Q4'22)
-
EPS growth Medical - Instruments & Supplies: +16.3%+86.7% ★ Q4'23: +125.0% (vs Q4'22)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-220.0% Q4'23: -8.1% (vs Q4'22)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-305.1% Q4'23: +132.1% (vs Q4'22)
-
ROIC Medical - Instruments & Supplies: +6.0%— Q4'23: -93.0% (vs Q4'22)
-
Share dilution Medical - Instruments & Supplies: +0.1%+41.4% Q4'23: +52.4% (vs Q4'22)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×-1.22× Q4'23: 3.46× (vs Q4'22)
| Metric |
Jun 2022 actual |
Jun 2023 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. |
|---|---|---|---|---|---|
| Revenue |
1.05M
est: 1.12M (-6.6%)
|
745.1K
est: 1.01M (-26.5%)
|
675.0K
est.
|
1.12M
1.12M – 1.12M
+65.9% YoY
|
1.01M
1.01M – 1.01M
-9.5% YoY
|
| EBITDA |
-12.96M
est: -969.3K (-1,237.1%)
|
-2.26M
est: -877.6K (-157.6%)
|
-584.2K
est.
|
-969.3K
-969.3K – -969.3K
-65.9% YoY
|
-877.6K
-877.6K – -877.6K
+9.5% YoY
|
| EBIT |
-12.97M
est: -972.4K (-1,233.7%)
|
-2.27M
est: -880.4K (-158.2%)
|
-586.0K
est.
|
-972.4K
-972.4K – -972.4K
-65.9% YoY
|
-880.4K
-880.4K – -880.4K
+9.5% YoY
|
| Net Income |
-13.05M
est: -15.36M (+15.0%)
|
-2.39M
|
—
est.
|
-15.36M
-15.36M – -15.36M
|
—
— – —
+100.0% YoY
|
| SGA |
13.12M
est: 4.52M (+190.1%)
|
2.50M
est: 4.10M (-39.0%)
|
2.73M
est.
|
4.52M
4.52M – 4.52M
+65.9% YoY
|
4.10M
4.10M – 4.10M
-9.5% YoY
|
| EPS |
-0.01
est: -0.01 (-20.0%)
|
0.00
|
—
est.
|
-0.01
-0.01 – -0.01
|
—
— – —
+100.0% YoY
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Capital Master Fund, L.P. | 5.09M | 10.21% | — | 5.09M | — | 5.09M | OO | United States | 2018-01-31 | ↗ |
| 2 | Lemak | 5.09M | 10.21% | — | 5.09M | — | 5.09M | IN | States | 2018-01-31 | ↗ |
| 3 | EIN 27-1699121 | — | 0.00% | — | — | — | — | PN | Martinez, California, USA | 2015-02-24 | ↗ |
| 4 | Joseph A. Noel | — | 0.00% | — | — | — | — | IN | Martinez, California, USA | 2015-02-24 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Peter Pizzino | President & Director | 279.7K | male |
| Eric Michael Sherb | Chief Financial Officer | 215.6K | male |
| Eric Sherb | Chief Financial Officer | 215.6K | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for WHSI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
